Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study

Creative Commons License

Ciftciler R., AKSU S., Dikmenoglu Falkmarken N., Celalettin Haznedaroglu I.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.49, sa.1, ss.356-360, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3906/sag-1808-60
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.356-360
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim: Ankaferd hemostat (ABS; Ankaferd blood stopper, Istanbul, Turkey) is a prohemostatic agent affecting erythrocytes. The hemostatic action of ABS depends upon fibrinogen gamma chain, prothrombin, and red blood cells. The aim of this study was to assess the effects of ABS on erythrocyte aggregation via hemorheological analyses.